{
    "title": "J&J raises profit forecast as trial halt weighs",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8834637/Johnson--Johnson-hikes-year-profit-forecast-pharma-strength.html",
    "date": "2020-10-13",
    "keywords": [
        "company",
        "share",
        "johnson",
        "drug",
        "profit",
        "vaccine",
        "illness",
        "device",
        "forecast",
        "time",
        "year",
        "day",
        "halt",
        "coronavirus",
        "investor",
        "fate",
        "finance",
        "chief",
        "joseph",
        "wolk",
        "suspension",
        "participant",
        "information",
        "data",
        "safety",
        "board",
        "amp",
        "drugmaker",
        "manufacturer",
        "thirdquarter",
        "tone",
        "quarter",
        "strength",
        "companys",
        "unit",
        "cancer",
        "darzalex",
        "imbruvica",
        "abbvie",
        "inc",
        "stelara",
        "covid19",
        "range",
        "basis",
        "refinitiv",
        "jampjs",
        "bell",
        "reporting",
        "bengaluru",
        "editing",
        "dasgupta",
        "patrick",
        "graham"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}